
STAAR Surgical Company (NASDAQ:STAA) specializes in developing, manufacturing, and marketing implantable lenses for the eye and delivery systems used to insert these lenses. Focused on innovation within the ophthalmic industry, STAAR aims to improve visual outcomes for patients with refractive errors. Their flagship products include the Visian ICL (Implantable Collamer® Lens), a leading alternative for correcting vision, and the Preloaded Injector, a device designed to enhance the safety and efficiency of lens implantation during surgery. STAAR Surgical's objectives center around expanding their global footprint, investing in research and development to advance their current product lineup, and providing eye care professionals with effective solutions to address a wide range of visual impairments. With a commitment to quality and patient satisfaction, STAAR continues to strive for excellence within the field of ophthalmic surgery.